Persons with dispensed medicines; origin

Edit table Show description

Persons with dispensed medicines; origin
Sex Age Origin Medicine group (ATC) Periods Persons with medicines, relative (%) Defined daily doses (DDD), relative (number per 1 000 persons)
Total male and female Total age Total G02B Contraceptives for topical use 2022* 0.09 1,375
Total male and female Total age Total G03A Hormonal contraceptives system. use 2022* 1.67 5,882
Total male and female Total age Origin: born in the Netherlands G02B Contraceptives for topical use 2022* 0.10 1,576
Total male and female Total age Origin: born in the Netherlands G03A Hormonal contraceptives system. use 2022* 1.91 6,763
Total male and female Total age Origin: born in NL, parents in NL G02B Contraceptives for topical use 2022* 0.10 1,640
Total male and female Total age Origin: born in NL, parents in NL G03A Hormonal contraceptives system. use 2022* 1.94 6,969
Total male and female Total age Origin: born in NL, parent(s) abroad G02B Contraceptives for topical use 2022* 0.08 1,167
Total male and female Total age Origin: born in NL, parent(s) abroad G03A Hormonal contraceptives system. use 2022* 1.70 5,464
Total male and female Total age Origin: born in NL, 1 parent born in NL G02B Contraceptives for topical use 2022* 0.11 1,676
Total male and female Total age Origin: born in NL, 1 parent born in NL G03A Hormonal contraceptives system. use 2022* 2.15 7,279
Total male and female Total age Origin: born in NL,2 parents born abroad G02B Contraceptives for topical use 2022* 0.04 548
Total male and female Total age Origin: born in NL,2 parents born abroad G03A Hormonal contraceptives system. use 2022* 1.14 3,256
Total male and female Total age Origin: born abroad G02B Contraceptives for topical use 2022* 0.02 328
Total male and female Total age Origin: born abroad G03A Hormonal contraceptives system. use 2022* 0.41 1,289
Total male and female Total age Origin country: The Netherlands G02B Contraceptives for topical use 2022* 0.10 1,640
Total male and female Total age Origin country: The Netherlands G03A Hormonal contraceptives system. use 2022* 1.94 6,969
Total male and female Total age Origin country: abroad G02B Contraceptives for topical use 2022* 0.05 677
Total male and female Total age Origin country: abroad G03A Hormonal contraceptives system. use 2022* 0.95 3,025
Total male and female Total age Origin country: Europe (excl. NL) G02B Contraceptives for topical use 2022* 0.06 879
Total male and female Total age Origin country: Europe (excl. NL) G03A Hormonal contraceptives system. use 2022* 0.98 3,292
Total male and female Total age Origin country: outside Europe G02B Contraceptives for topical use 2022* 0.04 571
Total male and female Total age Origin country: outside Europe G03A Hormonal contraceptives system. use 2022* 0.93 2,885
Total male and female Total age Origin country: Morocco G02B Contraceptives for topical use 2022* 0.02 205
Total male and female Total age Origin country: Morocco G03A Hormonal contraceptives system. use 2022* 0.57 1,537
Total male and female Total age Origin country: Turkey G02B Contraceptives for topical use 2022* 0.01 201
Total male and female Total age Origin country: Turkey G03A Hormonal contraceptives system. use 2022* 0.60 1,645
Total male and female Total age Origin country: Suriname G02B Contraceptives for topical use 2022* 0.04 574
Total male and female Total age Origin country: Suriname G03A Hormonal contraceptives system. use 2022* 1.40 4,393
Total male and female Total age Origin country: Dutch Caribbean G02B Contraceptives for topical use 2022* 0.06 959
Total male and female Total age Origin country: Dutch Caribbean G03A Hormonal contraceptives system. use 2022* 1.76 5,510
Total male and female Total age Origin country: Indonesia G02B Contraceptives for topical use 2022* 0.01 216
Total male and female Total age Origin country: Indonesia G03A Hormonal contraceptives system. use 2022* 0.33 1,154
Total male and female Total age Origin country: Outside Europe (exc. 5.. G02B Contraceptives for topical use 2022* 0.06 827
Total male and female Total age Origin country: Outside Europe (exc. 5.. G03A Hormonal contraceptives system. use 2022* 1.05 3,368
Total male and female 0 to 14 years Total G02B Contraceptives for topical use 2022* 0.00 24
Total male and female 0 to 14 years Total G03A Hormonal contraceptives system. use 2022* 0.57 1,586
Total male and female 0 to 14 years Origin: born in the Netherlands G02B Contraceptives for topical use 2022* 0.00 26
Total male and female 0 to 14 years Origin: born in the Netherlands G03A Hormonal contraceptives system. use 2022* 0.59 1,669
Total male and female 0 to 14 years Origin: born in NL, parents in NL G02B Contraceptives for topical use 2022* 0.00 30
Total male and female 0 to 14 years Origin: born in NL, parents in NL G03A Hormonal contraceptives system. use 2022* 0.70 1,989
Total male and female 0 to 14 years Origin: born in NL, parent(s) abroad G02B Contraceptives for topical use 2022* 0.00 15
Total male and female 0 to 14 years Origin: born in NL, parent(s) abroad G03A Hormonal contraceptives system. use 2022* 0.27 687
Total male and female 0 to 14 years Origin: born in NL, 1 parent born in NL G02B Contraceptives for topical use 2022* 0.00 23
Total male and female 0 to 14 years Origin: born in NL, 1 parent born in NL G03A Hormonal contraceptives system. use 2022* 0.41 1,092
Total male and female 0 to 14 years Origin: born in NL,2 parents born abroad G02B Contraceptives for topical use 2022* 0.00 6
Total male and female 0 to 14 years Origin: born in NL,2 parents born abroad G03A Hormonal contraceptives system. use 2022* 0.13 270
Total male and female 0 to 14 years Origin: born abroad G02B Contraceptives for topical use 2022* 0.00 1
Total male and female 0 to 14 years Origin: born abroad G03A Hormonal contraceptives system. use 2022* 0.22 541
Total male and female 0 to 14 years Origin country: The Netherlands G02B Contraceptives for topical use 2022* 0.00 30
Total male and female 0 to 14 years Origin country: The Netherlands G03A Hormonal contraceptives system. use 2022* 0.70 1,989
Total male and female 0 to 14 years Origin country: abroad G02B Contraceptives for topical use 2022* 0.00 11
Total male and female 0 to 14 years Origin country: abroad G03A Hormonal contraceptives system. use 2022* 0.26 651
Total male and female 0 to 14 years Origin country: Europe (excl. NL) G02B Contraceptives for topical use 2022* 0.00 7
Total male and female 0 to 14 years Origin country: Europe (excl. NL) G03A Hormonal contraceptives system. use 2022* 0.31 805
Total male and female 0 to 14 years Origin country: outside Europe G02B Contraceptives for topical use 2022* 0.00 13
Total male and female 0 to 14 years Origin country: outside Europe G03A Hormonal contraceptives system. use 2022* 0.24 583
Total male and female 0 to 14 years Origin country: Morocco G02B Contraceptives for topical use 2022* 0.00 0
Total male and female 0 to 14 years Origin country: Morocco G03A Hormonal contraceptives system. use 2022* 0.13 295
Total male and female 0 to 14 years Origin country: Turkey G02B Contraceptives for topical use 2022* 0.00 0
Total male and female 0 to 14 years Origin country: Turkey G03A Hormonal contraceptives system. use 2022* 0.17 382
Total male and female 0 to 14 years Origin country: Suriname G02B Contraceptives for topical use 2022* 0.00 45
Total male and female 0 to 14 years Origin country: Suriname G03A Hormonal contraceptives system. use 2022* 0.51 1,293
Total male and female 0 to 14 years Origin country: Dutch Caribbean G02B Contraceptives for topical use 2022* 0.00 4
Total male and female 0 to 14 years Origin country: Dutch Caribbean G03A Hormonal contraceptives system. use 2022* 0.45 1,168
Total male and female 0 to 14 years Origin country: Indonesia G02B Contraceptives for topical use 2022* 0.00 0
Total male and female 0 to 14 years Origin country: Indonesia G03A Hormonal contraceptives system. use 2022* 0.35 786
Total male and female 0 to 14 years Origin country: Outside Europe (exc. 5.. G02B Contraceptives for topical use 2022* 0.00 17
Total male and female 0 to 14 years Origin country: Outside Europe (exc. 5.. G03A Hormonal contraceptives system. use 2022* 0.22 544
Total male and female 15 to 24 years Total G02B Contraceptives for topical use 2022* 0.72 11,149
Total male and female 15 to 24 years Total G03A Hormonal contraceptives system. use 2022* 12.87 45,903
Total male and female 15 to 24 years Origin: born in the Netherlands G02B Contraceptives for topical use 2022* 0.81 12,702
Total male and female 15 to 24 years Origin: born in the Netherlands G03A Hormonal contraceptives system. use 2022* 14.64 52,448
Total male and female 15 to 24 years Origin: born in NL, parents in NL G02B Contraceptives for topical use 2022* 0.92 14,463
Total male and female 15 to 24 years Origin: born in NL, parents in NL G03A Hormonal contraceptives system. use 2022* 16.28 59,069
Total male and female 15 to 24 years Origin: born in NL, parent(s) abroad G02B Contraceptives for topical use 2022* 0.41 6,097
Total male and female 15 to 24 years Origin: born in NL, parent(s) abroad G03A Hormonal contraceptives system. use 2022* 8.47 27,612
Total male and female 15 to 24 years Origin: born in NL, 1 parent born in NL G02B Contraceptives for topical use 2022* 0.68 10,410
Total male and female 15 to 24 years Origin: born in NL, 1 parent born in NL G03A Hormonal contraceptives system. use 2022* 12.68 43,468
Total male and female 15 to 24 years Origin: born in NL,2 parents born abroad G02B Contraceptives for topical use 2022* 0.17 2,384
Total male and female 15 to 24 years Origin: born in NL,2 parents born abroad G03A Hormonal contraceptives system. use 2022* 4.85 13,963
Total male and female 15 to 24 years Origin: born abroad G02B Contraceptives for topical use 2022* 0.20 2,744
Total male and female 15 to 24 years Origin: born abroad G03A Hormonal contraceptives system. use 2022* 3.32 10,490
Total male and female 15 to 24 years Origin country: The Netherlands G02B Contraceptives for topical use 2022* 0.92 14,463
Total male and female 15 to 24 years Origin country: The Netherlands G03A Hormonal contraceptives system. use 2022* 16.28 59,069
Total male and female 15 to 24 years Origin country: abroad G02B Contraceptives for topical use 2022* 0.31 4,529
Total male and female 15 to 24 years Origin country: abroad G03A Hormonal contraceptives system. use 2022* 6.06 19,606
Total male and female 15 to 24 years Origin country: Europe (excl. NL) G02B Contraceptives for topical use 2022* 0.39 5,828
Total male and female 15 to 24 years Origin country: Europe (excl. NL) G03A Hormonal contraceptives system. use 2022* 6.21 21,102
Total male and female 15 to 24 years Origin country: outside Europe G02B Contraceptives for topical use 2022* 0.26 3,835
Total male and female 15 to 24 years Origin country: outside Europe G03A Hormonal contraceptives system. use 2022* 5.98 18,807
Total male and female 15 to 24 years Origin country: Morocco G02B Contraceptives for topical use 2022* 0.09 1,136
Total male and female 15 to 24 years Origin country: Morocco G03A Hormonal contraceptives system. use 2022* 3.01 8,142
Total male and female 15 to 24 years Origin country: Turkey G02B Contraceptives for topical use 2022* 0.09 1,279
Total male and female 15 to 24 years Origin country: Turkey G03A Hormonal contraceptives system. use 2022* 3.72 10,276
Total male and female 15 to 24 years Origin country: Suriname G02B Contraceptives for topical use 2022* 0.31 4,337
Total male and female 15 to 24 years Origin country: Suriname G03A Hormonal contraceptives system. use 2022* 10.29 32,577
Total male and female 15 to 24 years Origin country: Dutch Caribbean G02B Contraceptives for topical use 2022* 0.38 5,738
Total male and female 15 to 24 years Origin country: Dutch Caribbean G03A Hormonal contraceptives system. use 2022* 9.97 31,582
Total male and female 15 to 24 years Origin country: Indonesia G02B Contraceptives for topical use 2022* 0.42 6,118
Total male and female 15 to 24 years Origin country: Indonesia G03A Hormonal contraceptives system. use 2022* 9.15 32,029
Source: CBS.
Explanation of symbols

Dataset is not available.


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, origin, age and sex.

Data available from 2020.

Status of the figures:
Figures for 2022 are provisional.

Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.

When will new figures be published?
New figures will be published in the last quarter of 2024.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.
Defined daily doses (DDD), relative
Defined Daily Dose (DDD) is de door de WHO vastgestelde gemiddelde dagelijkse dosis van een geneesmiddel, wanneer het geneesmiddel wordt ingezet voor de hoofdindicatie, bij een onderhoudsbehandeling voor volwassenen. Deze definitie maakt het mogelijk om het gebruik van verschillende toedieningsvormen en verschillende middelen met elkaar te vergelijken.

WHO: World Health Organisation, Wereldgezondheidsorganisatie